QRVLX
Price
$33.09
Change
+$0.26 (+0.79%)
Updated
Jul 3 closing price
Net Assets
53.16M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

QRVLX vs VIVAX

Header iconQRVLX vs VIVAX Comparison
Open Charts QRVLX vs VIVAXBanner chart's image
FPA Queens Road Value
Price$33.09
Change+$0.26 (+0.79%)
VolumeN/A
Net Assets53.16M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
QRVLX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QRVLX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QRVLX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. QRVLX (53.2M). VIVAX pays higher dividends than QRVLX: VIVAX (2.06) vs QRVLX (1.18). QRVLX was incepted earlier than VIVAX: QRVLX (23 years) vs VIVAX (33 years). QRVLX (1.51) is less costly to investors than VIVAX (0.17). VIVAX has a lower initial minimum investment than QRVLX: VIVAX (3000) vs QRVLX (100000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. QRVLX (9.99). VIVAX return over 5 years is better than : 80.14 vs. QRVLX (58.85).
QRVLXVIVAXQRVLX / VIVAX
Total Expense Ratio0.650.17382%
Annual Report Gross Expense Ratio1.510.17888%
Fund Existence23 years33 years-
Gain YTD6.3306.209102%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets53.2M189B0%
Annual Yield % from dividends1.182.0657%
Returns for 1 year9.9912.0483%
Returns for 3 years50.9535.16145%
Returns for 5 years58.8580.1473%
Returns for 10 years91.97115.7479%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.